Abstract Background: Oxygen (O2) is a drug with specific biochemical and physiological
properties, a range of effective doses and may have side effects. In 2015, 14% of over …

The British Thoracic Society (BTS) Home Oxygen Guideline provides detailed evidence-
based guidance for the use of home oxygen for patients out of hospital. Although the …

Chronic Obstructive Pulmonary Disease (COPD) is a progressive pulmonary disorder
underpinned by poorly reversible airflow resulting from chronic bronchitis or emphysema …

Background The Standards for the Diagnosis and Treatment of Patients with COPD
document 2004 updates the position papers on chronic obstructive pulmonary disease …

Long-term oxygen treatment (LTOT) prolongs life in patients with chronic obstructive
pulmonary disease (COPD) and severe resting hypoxemia. Although this benefit is proven …

Lightweight ambulatory oxygen devices are provided on the assumptions that they enhance
compliance and increase activity, but data to support these assumptions are lacking. We …

Some chronic respiratory diseases can cause hypoxemia and, in such cases, long-term
home oxygen therapy (LTOT) is indicated as a treatment option primarily to improve patient …

Purpose Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death
worldwide and is associated with a growing and substantial socioeconomic burden. Long …

Hintergrund Sauerstoff (O 2) ist ein Arzneimittel mit spezifischen biochemischen und
physiologischen Eigenschaften, einem definierten Dosis-Wirkungsbereich und mit …

Abstract Background: The German guideline on long-term oxygen therapy (LTOT) was
published in 2008 by the German Respiratory Society (DGP), while the British Thoracic …